These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19162129)

  • 1. Rho GTPases in hepatocellular carcinoma.
    Grise F; Bidaud A; Moreau V
    Biochim Biophys Acta; 2009 Apr; 1795(2):137-51. PubMed ID: 19162129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling through Rho GTPase pathway as viable drug target.
    Lu Q; Longo FM; Zhou H; Massa SM; Chen YH
    Curr Med Chem; 2009; 16(11):1355-65. PubMed ID: 19355891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Involvement of small GTPase Rho and Rho-kinase in the pathogenesis of hypertension and hypertensive target organ damage].
    Nakayama M; Amano M; Kawabata S; Kaibuchi K; Takefuji M
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():202-6. PubMed ID: 15171369
    [No Abstract]   [Full Text] [Related]  

  • 4. Approaches of targeting Rho GTPases in cancer drug discovery.
    Lin Y; Zheng Y
    Expert Opin Drug Discov; 2015; 10(9):991-1010. PubMed ID: 26087073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rho GTPase function in tumorigenesis.
    Karlsson R; Pedersen ED; Wang Z; Brakebusch C
    Biochim Biophys Acta; 2009 Dec; 1796(2):91-8. PubMed ID: 19327386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatic analysis of RHO family of GTPases identifies RAC1 pharmacological inhibition as a new therapeutic strategy for hepatocellular carcinoma.
    Bayo J; Fiore EJ; Dominguez LM; Cantero MJ; Ciarlantini MS; Malvicini M; Atorrasagasti C; Garcia MG; Rossi M; Cavasotto C; Martinez E; Comin J; Mazzolini GD
    Gut; 2021 Jul; 70(7):1362-1374. PubMed ID: 33106353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ECT2 regulates the Rho/ERK signalling axis to promote early recurrence in human hepatocellular carcinoma.
    Chen J; Xia H; Zhang X; Karthik S; Pratap SV; Ooi LL; Hong W; Hui KM
    J Hepatol; 2015 Jun; 62(6):1287-95. PubMed ID: 25617497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Rho GTPase signalling pathway in urothelial carcinoma.
    Woldu SL; Hutchinson RC; Krabbe LM; Sanli O; Margulis V
    Nat Rev Urol; 2018 Feb; 15(2):83-91. PubMed ID: 29133936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RhoE is frequently down-regulated in hepatocellular carcinoma (HCC) and suppresses HCC invasion through antagonizing the Rho/Rho-kinase/myosin phosphatase target pathway.
    Ma W; Wong CC; Tung EK; Wong CM; Ng IO
    Hepatology; 2013 Jan; 57(1):152-61. PubMed ID: 22829315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rho/Rho kinase as a potential target for the treatment of renal disease.
    Wakino S; Kanda T; Hayashi K
    Drug News Perspect; 2005 Dec; 18(10):639-43. PubMed ID: 16491166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rho GTPases: promising cellular targets for novel anticancer drugs.
    Fritz G; Kaina B
    Curr Cancer Drug Targets; 2006 Feb; 6(1):1-14. PubMed ID: 16475973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered Rho GTPase signaling pathways in breast cancer cells.
    Burbelo P; Wellstein A; Pestell RG
    Breast Cancer Res Treat; 2004 Mar; 84(1):43-8. PubMed ID: 14999153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho family GTPases cooperate with p53 deletion to promote primary mouse embryonic fibroblast cell invasion.
    Guo F; Zheng Y
    Oncogene; 2004 Jul; 23(33):5577-85. PubMed ID: 15122327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rho-family GTPases in cadherin-mediated cell-cell adhesion.
    Fukata M; Kaibuchi K
    Nat Rev Mol Cell Biol; 2001 Dec; 2(12):887-97. PubMed ID: 11733768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.
    Wong CM; Yam JW; Ching YP; Yau TO; Leung TH; Jin DY; Ng IO
    Cancer Res; 2005 Oct; 65(19):8861-8. PubMed ID: 16204057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Rho signaling pathways in interleukin-2-stimulated human T-lymphocytes.
    Mzali R; Seguin L; Liot C; Auger A; Pacaud P; Loirand G; Thibault C; Pierre J; Bertoglio J
    FASEB J; 2005 Nov; 19(13):1911-3. PubMed ID: 16148026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rho proteins and cancer.
    Ridley AJ
    Breast Cancer Res Treat; 2004 Mar; 84(1):13-9. PubMed ID: 14999150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rho GTPases in human cancer: an unresolved link to upstream and downstream transcriptional regulation.
    Benitah SA; Valerón PF; van Aelst L; Marshall CJ; Lacal JC
    Biochim Biophys Acta; 2004 Dec; 1705(2):121-32. PubMed ID: 15588766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taking Rho GTPases to the next level: the cellular functions of atypical Rho GTPases.
    Aspenström P; Ruusala A; Pacholsky D
    Exp Cell Res; 2007 Oct; 313(17):3673-9. PubMed ID: 17850788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell proliferation and drug resistance in hepatocellular carcinoma are modulated by Rho GTPase signals.
    Sterpetti P; Marucci L; Candelaresi C; Toksoz D; Alpini G; Ugili L; Baroni GS; Macarri G; Benedetti A
    Am J Physiol Gastrointest Liver Physiol; 2006 Apr; 290(4):G624-32. PubMed ID: 16322093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.